The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Clinical and Biological Features in the Prognosis of Adrenocortical Cancer: Poor Outcome of Cortisol-Secreting Tumors in a Series of 202 Consecutive Patients
Abstract
CONTEXT: Adrenocortical carcinomas (ACC) are rare tumors with a poor prognosis. Few reports concerning large and homogeneous series are available. OBJECTIVE: We aimed to determine the clinical characteristics and outcome of ACC and to identify prognostic factors. DESIGN AND SETTING: This study is a descriptive and multivariate analysis of a cohort from a single endocrinology center. PATIENTS: A total of 202 consecutive patients with ACC were studied. RESULTS: The sex ratio (female to male) was 2.7. Mean age at diagnosis was 44 +/- 16 yr (range, 11-88 yr). We found that 154 patients (76%) had hypersecreting tumors [mostly cortisol and androgens (47%), cortisol alone (27%), or androgens alone (6%)] and 43 patients (21%) had metastases at diagnosis. At initial staging or during follow-up, 85 patients (42%) had liver metastases, 79 patients (39%) had lung metastases, and 20 patients had bone metastases (10%). The survival rate was 37% at 5 yr. Multivariate analysis identified the following independent prognostic factors associated with shorter survival: older age at diagnosis [hazard ratio (HR), 1.03; P < 0.0001], initial MacFarlane extension stages 3 (HR, 4.42; P = 0.005) and 4 (HR, 7.93; P < 0.0001), and cortisol hypersecretion (HR, 3.90; P < 0.0001). Treatment with 1,1-dichlorodiphenildichloroethane (o,p'DDD) in the 3 months after surgery increased the survival rate of patients with cortisol-secreting tumors (HR, 0.40; P = 0.04). CONCLUSION: This study highlights the better prognosis of ACC diagnosed at a noninvasive local stage, the particularly poor prognosis of patients with cortisol-secreting tumors, and the beneficial effect of o,p'DDD therapy in this subgroup of patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The impact of the functional status and clinical features of ACCs on survival is unclear (132,133).”
From Adrenal incidentaloma (2020) · cites this paper as [133]
In the citing paper
“Biochemically or clinically apparent adrenocortical hormone production is evident in up to 45% to 70% (9, 10, 85).”
From Adrenocortical carcinoma (2014) · cites this paper as [85]
In the citing paper
“Autonomous aldosterone secretion (which classically leads to hypertension and hypokalemia) is rare in ACC (85, 86).”
From Adrenocortical carcinoma (2014) · cites this paper as [85]
In the citing paper
“At the time of presentation, ACCs are generally large tumors, measuring on average 10 to 13 cm (9, 85, 89).”
From Adrenocortical carcinoma (2014) · cites this paper as [85]
In the citing paper
“Hypercortisolism is the most common presentation of patients presenting with hormone excess (50%–80% of hormone-secreting ACCs), causing classic symptoms including plethora, diabetes mellitus, muscle weakness/atrophy, and osteoporosis.”
From Adrenocortical carcinoma (2014) · cites this paper as [85]
In the citing paper
“some recent studies identified cortisol production as an adverse prognostic factor (12, 85, 244).”
From Adrenocortical carcinoma (2014) · cites this paper as [85]
Citations
Cites
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
Devesa, S. S., Blot, W. J., & Fraumeni, J. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10 · Cited by 2,097
Incidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt‐Rasmussen, U., Hagen, C., Jørgensen, J. O. L., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 763
Luton, J.-P., Cerdas, S., Billaud, L., Thomas, G., Guilhaume, B., Bertagna, X., Laudat, M.-H., Louvel, A., Chapuis, Y., Blondeau, P., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004263221705 · Cited by 717
Self-citationIcard, P., Goudet, P., Charpenay, C., Andreassian, B., Carnaille, B., Chapuis, Y., Cougard, P., Henry, J., & Proye, C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0047-y · Cited by 543
Tissier, F., Cavard, C., Groussin, L., Perlemoine, K., Fumey, G., Hagneré, A.-M., René-Corail, F., Jullian, E., Gicquel, C., Bertagna, X., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0593 · Cited by 474
Self-citationBerruti, A., Terzolo, M., Sperone, P., Pia, A. R., Casa, S. D., Gross, D. J., Carnaghi, C., Casali, P. G., Porpiglia, F., Mantero, F., et al. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01025 · Cited by 308
Gicquel, C., BERTAGNA, X. Y., Gaston, V., Coste, J., Louvel, A., Baudin, É., Bertherat, J. Y., Chapuis, Y., Duclos, J. M., Schlumberger, M. J., et al. (2001) · PubMed · Cited by 285
Self-citationHutter, A. M., & Kayhoe, D. E. (1966) · The American Journal of Medicine · doi:10.1016/0002-9343(66)90219-1 · Cited by 277
Hutter, A. M., & Kayhoe, D. E. (1966) · The American Journal of Medicine · doi:10.1016/0002-9343(66)90220-8 · Cited by 271
Macfarlane, D. A. (1958) · PubMed · Cited by 266
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–446 of 446
Marinova, L., Vasileva, V., Gabrovski, I., Petrov, V., & Kahchiev, N. (2022) · Journal of Pediatrics Research Reviews & Reports · doi:10.47363/jprrr/2022(4)144
Adrenocortical Tumor: With Special Reference to A Case Report
Abdellah, M., Dahbi-Skali, L., Iliass, M., & Settaf, A. (2022) · Scholars Journal of Medical Case Reports · doi:10.36347/sjmcr.2022.v10i09.001
Malignant Adrenocortical Carcinoma - Case Report
Mazzini, L. R., Paiva, D. F., Micelli, I. P., Siquelli, F. A. F., Costa, R. S., Pinheiro, S. A. F., Mattion, E. A., & Samartine, H. (2022) · Acta Scientific Gastrointestinal Disorders · doi:10.31080/asgis.2022.05.0487
Kawan, F., & Fornara, P. (2022) · Springer Reference Medizin · doi:10.1007/978-3-642-41168-7_32-3
Carcinoma suprarrenal funcionante metastásico
Nigro, E., Rossi, J., & Tomadoni, A. (2013) · Oncología Clínica · doi:10.56969/oc.v18i1.120
Gaujoux, S., Grabar, S., Faßnacht, M., Ragazzon, B., Launay, P., Libé, R., Chokri, I., Audebourg, A., Royer, B., Sbiera, S., et al. (2023) · doi:10.1158/1078-0432.c.6519798.v1
Self-citationPluta, E., Michta, M., Patla, A., Mucha-Małecka, A., Wójcicki, K., & Madej, P. B. (2023) · Nowotwory Journal of Oncology · doi:10.5603/njo.2023.0015
中田, 竜., 吉澤, 都., 米澤, 淳., 草開, 友., 瀬戸, 親., & 内山, 明. (2023) · Folia Endocrinologica Japonica · doi:10.1507/endocrine.99.s.update_41
Kawan, F., & Fornara, P. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-63400-4_32
Devi, J., & Phukan, N. (2023) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2023.5.5.1892
The problem of adrenocortical cancer therapy
Андреевна, К. А., Горбунова, В. А., & Переводчикова, Н. И. (2014) · Russian Journal of Oncology · doi:10.17816/onco40131
Barat, M., Eltaher, M., Moawad, A. W., Soyer, P. A., Fuentes, D., Golse, M., Jouinot, A., Ahmed, A. A., Shehata, M., Assié, G., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3910331/v1
Self-citationExpertise Area 3.3: Adrenal cancer
Langenhuijsen, J. F., Miletić, M., Solak, M., Esteban, M. D., Mancini, M., Hompes, D., Kuliš, T., Fuchs, J., Amend, B., & Fröbe, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99934-2.00009-7
Kerdivel, G., Amrouche, F., Calméjane, M.-A., Carallis, F., Hamroune, J., Hantel, C., Bertherat, J. Y., Assié, G., & Boeva, V. (2023) · Figshare · doi:10.6084/m9.figshare.23819919
Self-citationKerdivel, G., Amrouche, F., Calméjane, M.-A., Carallis, F., Hamroune, J., Hantel, C., Bertherat, J. Y., Assié, G., & Boeva, V. (2023) · Figshare · doi:10.6084/m9.figshare.23819907
Self-citationKerdivel, G., Amrouche, F., Calméjane, M.-A., Carallis, F., Hamroune, J., Hantel, C., Bertherat, J. Y., Assié, G., & Boeva, V. (2023) · Figshare · doi:10.6084/m9.figshare.23819931
Self-citationKerdivel, G., Amrouche, F., Calméjane, M.-A., Carallis, F., Hamroune, J., Hantel, C., Bertherat, J. Y., Assié, G., & Boeva, V. (2023) · Figshare · doi:10.6084/m9.figshare.23819928
Self-citationKerdivel, G., Amrouche, F., Calméjane, M.-A., Carallis, F., Hamroune, J., Hantel, C., Bertherat, J. Y., Assié, G., & Boeva, V. (2023) · Figshare · doi:10.6084/m9.figshare.23819904
Self-citationKerdivel, G., Amrouche, F., Calméjane, M.-A., Carallis, F., Hamroune, J., Hantel, C., Bertherat, J. Y., Assié, G., & Boeva, V. (2023) · Figshare · doi:10.6084/m9.figshare.23819898
Self-citationKerdivel, G., Amrouche, F., Calméjane, M.-A., Carallis, F., Hamroune, J., Hantel, C., Bertherat, J. Y., Assié, G., & Boeva, V. (2023) · Figshare · doi:10.6084/m9.figshare.23819922
Self-citationKerdivel, G., Amrouche, F., Calméjane, M.-A., Carallis, F., Hamroune, J., Hantel, C., Bertherat, J. Y., Assié, G., & Boeva, V. (2023) · Figshare · doi:10.6084/m9.figshare.23819901
Self-citationKerdivel, G., Amrouche, F., Calméjane, M.-A., Carallis, F., Hamroune, J., Hantel, C., Bertherat, J. Y., Assié, G., & Boeva, V. (2023) · Figshare · doi:10.6084/m9.figshare.23819913
Self-citationKerdivel, G., Amrouche, F., Calméjane, M.-A., Carallis, F., Hamroune, J., Hantel, C., Bertherat, J. Y., Assié, G., & Boeva, V. (2023) · Figshare · doi:10.6084/m9.figshare.23819910
Self-citationKerdivel, G., Amrouche, F., Calméjane, M.-A., Carallis, F., Hamroune, J., Hantel, C., Bertherat, J. Y., Assié, G., & Boeva, V. (2023) · Figshare · doi:10.6084/m9.figshare.23819916
Self-citationKerdivel, G., Amrouche, F., Calméjane, M.-A., Carallis, F., Hamroune, J., Hantel, C., Bertherat, J. Y., Assié, G., & Boeva, V. (2023) · Figshare · doi:10.6084/m9.figshare.23819925
Self-citationNael, A. (2024) · International Journal of Clinical Case Reports and Reviews · doi:10.31579/2690-4861/385
Management of Endocrine Syndromes Associated with Adrenocortical Carcinoma
Borin, C., Puglisi, S., Calabrese, A., Perotti, P., & Terzolo, M. (2024) · Updates in surgery/Updates in surgery series · doi:10.1007/978-3-031-62301-1_6
Lugo, L. M. P., & Franco, Á. E. O. (2024) · Revista Colombiana de Hematología y Oncología · doi:10.51643/22562915.699
Venkataramani, K., Krishnamurthy, S. S., Narayanaswamy, K., & Raja, A. (2025) · Urologia Journal · doi:10.1177/03915603251381390
Adrenocortical Carcinoma and Inferior Vena Cava Thrombosis: Diagnosis and Perioperative Management
Kallarackal, J., Jalla, A., Caputo-Seidler, J., & Dahl, J. (2025) · Cureus · doi:10.7759/cureus.98379
Zhang, F., Liu, Z., Liang, J., Liu, S., Wu, K., Zhang, F., Zhou, C., Lu, Y., Zhu, Y., & Wang, X. (2021) · Figshare · doi:10.6084/m9.figshare.16456506
Kerdivel, G., Amrouche, F., Calméjane, M.-A., Carallis, F., Hamroune, J., Hantel, C., Bertherat, J. Y., Assié, G., & Boeva, V. (2023) · Figshare · doi:10.6084/m9.figshare.23819895
Self-citationRodriguez, M. A., Sivakumar, H., Popova, L. V., Derakhshesh, S., Chopyk, D. M., Miles, W. O., Dedhia, P. H., & Skardal, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.08.698468
Chen, B., Foo, C., Andersson, A., Kayser, B. D., Yang, Y., Missarova, A., Kulkarni, P., Huetter, J.-C., Chatterjee, S., Kim, Y. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.16.697961 · Cited by 1
Hepatic embolization for Cushing syndrome from metastatic tumors: a single-center case series
Zhang, S., Mosquera, J. E., Musonza, C., Pillai, A., Abramowitz, J. D., Mirfakhraee, S., Polanco, P. M., Mutar, S. S. A., Arafat, W., & Hamidi, O. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag046
Patched as a new target for adrenocortical carcinoma treatment
Hasanovic, A. (2018) · theses.fr (ABES) · doi:10.70675/e4759414z32e1z4e77zbb6fz743df9c365d0
Guerrero‐Pérez, F., Planas, M. T., Espejo, C. W., Angulo, C. S., de Reynoso, R. M., Rubio, I. O., Simó-Servat, A., Corchuelo, J. C., Perez-Maraver, M., & Vilarrasa, N. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04409-2
Friedman, L. R., Smith, E. C., Sarvestani, A. L., Eade, A. V., Ho, J., Pu, T., Larrain, C. M., Hannah, C. E., Magee, T., Smith, K. M., et al. (2026) · BMC Cancer · doi:10.1186/s12885-026-16425-0
Gemcitabine and oxaliplatin combination in patients with advanced adrenocortical carcinoma
Chen, L., Balderrama-Brondani, V., Marcal, L. P., Jiménez, C., Varghese, J. M., Shah, A. Y., Habra, M. A., & Campbell, M. T. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag152
Frequent antecedent nodules and diagnostic gaps in adrenocortical carcinoma
Mohan, D. R., Weimholt, C., Brunt, L. M., Brown, T. C., & Jasim, S. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag161
ELAVL1-KO Affects Steroid Synthesis in ACC Cell Line NCI-H295R and Reduces Colony-Forming Abilities
Brandau, M., Kirsch, V., Chernyakov, D., Landwehr, L., Sbiera, S., & Edemir, B. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27157001
Castro, M. A., Bancos, I., Detomas, M., Reincke, M., Kaštelan, D., Naglic, M., Nekić, A. B., Biagetti, B., Casteràs, A., Cardona-Arias, A., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag373
Bettini, D. L., Rodella, S., Laganà, M., Turla, A., Berruti, A., & Cosentini, D. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag262
Metadata
- Authors
- Abiven, G., Coste, J., Groussin, L., Anract, P., Tissier, F., Legmann, P., Dousset, B., Bertagna, X., & Bertherat, J.
- Affiliations
- Hôpital Cochin (FR)
- Centre National de la Recherche Scientifique (FR)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-07
- Volume
- 91
- Issue
- 7
- Pages
- 2650-2655
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2140991656
- Cited by
- 435
- References
- 34
- Citations by year
- 2026: 12 · 2025: 12 · 2024: 14 · 2023: 23 · 2022: 20 · 2021: 30 · 2020: 25 · 2019: 23 · 2018: 33 · 2017: 17 · 2016: 23 · 2015: 32 · 2014: 31 · 2013: 21 · 2012: 18
- FWCI
- 15.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- adrenocortical carcinoma, prognosis, prognostic factors, survival, liver metastasis, lung metastasis, age at diagnosis, mitotane, adjuvant chemotherapy, androgen-secreting tumor
- MeSH terms
- Adrenal Cortex Neoplasms, Adult, Analysis of Variance, Androgens, Bone Neoplasms, Female, Humans, Hydrocortisone, Liver Neoplasms, Lung Neoplasms, Male, Middle Aged, Mitotane, Neoplasm Staging, Prognosis, Survival Rate, Chemotherapy, Adjuvant, Antineoplastic Agents, Hormonal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
